General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Mesoblast(MODEST), Novartis(MODEST), Merck(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Tenaya(MODEST), Foundry Innovation and Research(MODEST), Ionis(MODEST), Tenaya(MODEST) RESEARCH/RESEARCH GRANTS: Rocket Pharma(NONE) OTHER FINANCIAL BENEFIT: ACI(SIGNIFICANT)

View Full Disclosure